Olpruva Kit
NDC 72542-600
Product Information
Olpruva (sodium phenylbutyrate) is a NDA-approved product labeled by Acer Therapeutics Inc.. This medication is used along with diet changes for long-term treatment of a certain inherited disorder (urea cycle disorder). It is supplied as a kit for oral administration. This product entry covers the primary NDC 72542-600 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 72542-600?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SODIUM PHENYLBUTYRATE (UNII: NT6K61736T)
- PHENYLBUTYRIC ACID (UNII: 7WY7YBI87E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POLYETHYLENE GLYCOL 6000 (UNII: 30IQX730WE)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)
- TALC (UNII: 7SEV7J4R1U)
- DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER (UNII: 905HNO1SIH)
- STARCH, CORN (UNII: O8232NY3SJ)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2626369 - sodium phenylbutyrate 2 GM Granules for Oral Suspension
- RxCUI: 2626369 - sodium phenylbutyrate 2000 MG Granules for Oral Suspension
- RxCUI: 2626375 - OLPRUVA 2 GM Granules for Oral Suspension
- RxCUI: 2626375 - sodium phenylbutyrate 2000 MG Granules for Oral Suspension [Olpruva]
- RxCUI: 2626375 - Olpruva 2 GM Granules for Oral Suspension
* Please review the full disclaimer at the bottom of this page.